Tolga Kosecı

8PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 21, 2026
Questioning the association between prophylactic antibiotics and improved prognosis in gastric cancer immunotherapy.

Yusuf Ilhan, Tolga Kosecı

|Feb 21, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

|Nov 17, 2025
Real-world comparison of doxorubicin-ifosfamide versus gemcitabine-docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study.

Salih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel

|Apr 19, 2023
Brigatinib-associated autoimmune hepatitis: A case report.

Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir

|Jan 17, 2022
Panitumumab Associated Acute Pancreatitis.

Huseyin Can Arbag, Hilmi Erdem Sumbul, Mahmut Buyuksimsek

|Nov 10, 2021
Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma.

Mahmut Bakir Koyuncu, Erkan Guler, Tolga Koseci

Pageof 2

Frequent Collaborators

2 joint publications

Havva Yesil Cinkir

2 joint publications

Elif Sahin

2 joint publications

Sedat Biter

2 joint publications

Berna Bozkurt Duman